News

Investigational Agent Linaclotide Reduces Chronic Constipation


 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

This study was supported by Ironwood Pharmaceuticals and Forest Research Institute, the developers of linaclotide. Dr. Lembo reported receiving consulting and/or honorarium and other fees from both companies, as well as grant funding from Novartis, and serving as a consultant for numerous other companies. The other authors reported being employed by, and owning stock or stock options in, either Ironwood Pharmaceuticals or Forest Research Institute.

Pages

Recommended Reading

Endoscopic Resection Sufficient for Many T1 Colorectal Cancers
MDedge Internal Medicine
Gastric Bypass Surgery Increases Risk of Fractures
MDedge Internal Medicine
FDA Considers Infliximab for Pediatric Ulcerative Colitis Maintenance
MDedge Internal Medicine
Bariatric Surgery Now 'Safer Than Appendectomy'
MDedge Internal Medicine
Radiofrequency Ablation Works Well for Dysplatic Barrett's Esophagus
MDedge Internal Medicine
Comorbidities Often Preclude Transplants in Nonalcoholic Steatohepatitis
MDedge Internal Medicine
Mutations Linked to Esophageal Adenocarcinoma, Barrett's Esophagus
MDedge Internal Medicine
Hepatitis Prevalence Among Drug Users Varies Greatly Worldwide
MDedge Internal Medicine
Response to Locoregional Embolization Predicts Survival in Liver Cancer
MDedge Internal Medicine
NOTES Trial Assesses Cholecystectomy Approaches
MDedge Internal Medicine